Emerging Trends Influencing The Growth Of The Liver Cirrhosis Market: Introduction Of Innovative Implantable Device Approved For Advanced Treatment

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Big Is the Liver Cirrhosis Market Size Expected to Be by 2034?
In recent times, the market size for liver cirrhosis has experienced swift growth. Projected growth reflects an increase from $1.86 billion in 2024 to $2.01 billion in 2025, suggesting a compound annual growth rate (CAGR) of 8.3%. This growth throughout the historical period is prompted by factors such as a rise in liver-related diseases, higher alcohol intake, an aging demographic, a surge in spending on healare, as well as expanded government initiatives.

Expectations are high for a quick expansion in the liver cirrhosis market over the coming years. The market is projected to reach $2.74 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. This growth during the forecasted period could be the result of an upswing in hepatitis infections, economic development, increased urbanization, alterations in lifestyle, and an expansion in medical tourism. The period is likely to see trends such as improvements in diagnostic instruments, advancements in technology, collaborations and partnerships, the introduction of artificial intelligence, and the incorporation of holistic treatment methodologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

What Are the Emerging Segments Within the Liver Cirrhosis Market?
The liver cirrhosis market covered in this report is segmented -

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis
2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments
3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis
2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis
3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis
4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis
5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Long-Term Drivers Are Shaping Liver Cirrhosis Market Trends?
The liver cirrhosis market's growth is expected to be fuelled by the escalating alcohol consumption. Typically gauged in terms of quantity and frequency, alcohol consumption refers to the intake of alcoholic beverages. The rise in alcohol intake is attributed to its role in relieving daily stress, promoting social bonds at events, and enriching relaxation moments, coupled with its widespread endorsement in media and its growing accessibility in different environments. The treatment of liver cirrhosis in patients with a high alcohol intake is centered on managing liver damage with the aid of abstinence, medication, and supportive care, simultaneously addressing alcohol dependence via counseling and rehabilitation. For instance, in March 2023, the National Drugs Library, a data collection institution based in Ireland, reported that in 2022, the average alcohol consumption in individuals over 15 years old increased to 10.2 liters of pure alcohol per capita, indicating a 7.6% growth from 2021. Hence, the rise in alcohol consumption propels the liver cirrhosis market.

Who Are the Top Competitors in Key Liver Cirrhosis Market Segments?
Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

What Liver Cirrhosis Market Trends Are Gaining Traction Across Different Segments?
Key players in the liver cirrhosis market are prioritizing the evolution of treatment choices, like the creation of active implantable medical devices, in an effort to improve patient results and broaden therapeutic alternatives. Active implantable medical devices are electronically propelled implants engineered to monitor, sustain, or enhance the performance of an organ within the body. For example, in December 2024, a medical device company based in Belgium, Sequana Medical NV, acquired U.S. FDA approval for their alfapump system, marking it as the first active implantable medical device in the U.S. for dealing with recurrent or refractory ascites due to liver cirrhosis. This innovative technology provides a constant, automated approach for fluid management, rerouting excessive abdominal fluid to the bladder and significantly diminishing the reliance on invasive therapeutic paracentesis. The alfapump signifies a substantial progress in improving patient results and augmenting the quality of life, targeting a market of about 70,000 patients across the United States.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Regions Are Becoming Hubs for Liver Cirrhosis Market Innovation?
North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Cirrhosis Market?
2. What is the CAGR expected in the Liver Cirrhosis Market?
3. What Are the Key Innovations Transforming the Liver Cirrhosis Industry?
4. Which Region Is Leading the Liver Cirrhosis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.